학술논문
232P Second-line therapies of patients with early progression under CDK4/6-inhibitor in first-line – data from the registry platform OPAL
Document Type
Abstract
Author
Source
In Annals of Oncology September 2022 33 Supplement 7:S643-S644
Subject
Language
ISSN
0923-7534